Numinus Bioscience

Numinus Bioscience is on the path to discovery of potential benefits in other conditions with pronounced comorbidities of depression and anxiety. Using our internal expertise in Mycology, Chemistry, Immunochemistry, Phytochemistry, Formulation and Extraction coupled with state-of-the-art equipment, Numinus is developing patented technologies for efficiencies in production of psychoactive mushroom species, delivery of stable and sustainable medicines for use in specific disease paradigms with proven bioactivity, safety and efficacy

Numinus bioscience operates in the Research services industry.

Numinus bioscience's revenue is 11m - 100m

Numinus bioscience has 11 - 50 employees.